These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Amirouche A; Durieux AC; Banzet S; Koulmann N; Bonnefoy R; Mouret C; Bigard X; Peinnequin A; Freyssenet D Endocrinology; 2009 Jan; 150(1):286-94. PubMed ID: 18801898 [TBL] [Abstract][Full Text] [Related]
24. Progranulin compensates for blocked IGF-1 signaling to promote myotube hypertrophy in C2C12 myoblasts via the PI3K/Akt/mTOR pathway. Hu SY; Tai CC; Li YH; Wu JL FEBS Lett; 2012 Sep; 586(19):3485-92. PubMed ID: 22967900 [TBL] [Abstract][Full Text] [Related]
25. SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force. Watt KI; Jaspers RT; Atherton P; Smith K; Rennie MJ; Ratkevicius A; Wackerhage H Muscle Nerve; 2010 May; 41(5):624-9. PubMed ID: 20151464 [TBL] [Abstract][Full Text] [Related]
26. Myostatin inactivation increases myotube size through regulation of translational initiation machinery. Rodriguez J; Vernus B; Toubiana M; Jublanc E; Tintignac L; Leibovitch S; Bonnieu A J Cell Biochem; 2011 Dec; 112(12):3531-42. PubMed ID: 21769921 [TBL] [Abstract][Full Text] [Related]